Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.

@article{Komatsu2009OverexpressionOS,
  title={Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.},
  author={S. Komatsu and I. Imoto and H. Tsuda and K. Kozaki and T. Muramatsu and Y. Shimada and S. Aiko and Y. Yoshizumi and D. Ichikawa and E. Otsuji and J. Inazawa},
  journal={Carcinogenesis},
  year={2009},
  volume={30 7},
  pages={
          1139-46
        }
}
Although we have identified two putative targets, ATF3 and CENPF, for a frequently gained/amplified region around 1q32-q41 in esophageal squamous cell carcinoma (ESCC), it is possible that other amplification targets remain to be identified. In this study, we tested whether SET and MYND domain-containing protein 2 (SMYD2), located between those two genes and encoding a lysine methyltransferase for histone H3K36 and p53K370 that regulates transcription and inhibits transactivation activity… Expand
Overexpression of SMYD2 contributes to malignant outcome in gastric cancer
Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma
Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.
YAP is a candidate oncogene for esophageal squamous cell carcinoma.
TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer
Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma.
  • S. Natsugoe, S. Nakashima, +8 authors T. Aikou
  • Medicine, Biology
  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 1999
Molecular biology of esophageal squamous cell carcinoma.
  • A. Lam
  • Biology, Medicine
  • Critical reviews in oncology/hematology
  • 2000
...
1
2
3
...